Skip to content

Clinical trials

Phase 4 Coronary Artery Disease trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 4 Country / region: United Kingdom Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20064
20071
20093
20122
20152
20161
20171
20181
20191
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated3
Withdrawn3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices3
University of Glasgow2
Baim Institute for Clinical Research1
Craigavon Area Hospital1
Daiichi Sankyo1
Imperial College London1
Liverpool Heart and Chest Hospital NHS Foundation Trust1
Newcastle-upon-Tyne Hospitals NHS Trust1
OrbusNeich1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease21
Coronary Stenosis4
Myocardial Ischemia4
Acute Coronary Syndrome3
Angina Pectoris3
Coronary Restenosis3
Diabetes Mellitus, Type 23
Vascular Diseases3
Atherosclerosis2
Coronary Disease2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.